Filing Details

Accession Number:
0001209191-23-049178
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-12 20:07:51
Reporting Period:
2023-09-08
Accepted Time:
2023-09-12 20:07:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651944 Dermtech Inc. DMTK Services-Medical Laboratories (8071) 842870849
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1701970 M Kevin Sun C/O Dermtech, Inc.
12340 El Camino Real
San Diego CA 92130
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-09-08 223 $1.93 292,318 No 4 S Direct
Common Stock Disposition 2023-09-08 2,703 $1.93 289,615 No 4 S Direct
Common Stock Disposition 2023-09-08 3,058 $1.93 286,557 No 4 S Direct
Common Stock Disposition 2023-09-08 3,196 $1.93 283,361 No 4 S Direct
Common Stock Disposition 2023-09-11 436 $1.89 282,925 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
  2. Includes 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2023.
  3. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 23, 2022.
  4. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 7, 2023.
  5. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.
  6. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 24, 2020.